King of Prussia, PA, United States of America

Leandro Santos

USPTO Granted Patents = 6 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • King of Prussia, PA (US) (2019 - 2023)
  • Research Triangle Park, NC (US) (2019 - 2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Leandro Santos: Innovator in Topical Pharmaceutical Compositions

Introduction

Leandro Santos is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical compositions. With a total of six patents to his name, Santos has established himself as a key figure in his industry.

Latest Patents

Santos's latest patents focus on topical pharmaceutical emulsion compositions. These compositions comprise a therapeutically effective amount of 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a pharmaceutically acceptable salt thereof, along with an oil phase, a water phase, a surfactant, and an antioxidant. The emulsion composition is designed to be homogeneous, ensuring that the active ingredient is solubilized in the oil phase. Furthermore, the invention includes methods for treating dermatological conditions or disorders by administering these compositions to the skin of patients.

Career Highlights

Leandro Santos is currently associated with Dermavant Sciences GmbH, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing topical treatments that can significantly improve patient outcomes.

Collaborations

Santos collaborates with talented professionals in his field, including Sujatha D Sonti and Joey Roger Thomas. These partnerships enhance the research and development efforts at Dermavant Sciences GmbH.

Conclusion

Leandro Santos is a prominent inventor whose work in topical pharmaceutical compositions has the potential to impact many lives. His dedication to innovation and collaboration in the pharmaceutical industry is commendable.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…